These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22791367)

  • 61. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
    Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
    Murillo-Sauca O; Chung MK; Shin JH; Karamboulas C; Kwok S; Jung YH; Oakley R; Tysome JR; Farnebo LO; Kaplan MJ; Sirjani D; Divi V; Holsinger FC; Tomeh C; Nichols A; Le QT; Colevas AD; Kong CS; Uppaluri R; Lewis JS; Ailles LE; Sunwoo JB
    Oncotarget; 2014 Aug; 5(16):6854-66. PubMed ID: 25149537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
    Sayed SI; Dwivedi RC; Katna R; Garg A; Pathak KA; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Oral Oncol; 2011 Apr; 47(4):237-43. PubMed ID: 21382740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
    Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
    Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.
    Yata K; Beder LB; Tamagawa S; Hotomi M; Hirohashi Y; Grenman R; Yamanaka N
    Int J Oncol; 2015 Oct; 47(4):1249-56. PubMed ID: 26323893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 68. [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].
    Pries R; Wittkopf N; Hasselbacher K; Wollenberg B
    HNO; 2008 Apr; 56(4):461-6. PubMed ID: 18368378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
    Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
    J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma.
    Davis SJ; Divi V; Owen JH; Bradford CR; Carey TE; Papagerakis S; Prince ME
    Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1260-6. PubMed ID: 21173377
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comments on 'CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits', Se-Yeong Oh et al., European Journal of Cancer, published online 6 July 2012.
    Zheng S; Franzmann EJ
    Eur J Cancer; 2013 Oct; 49(15):3380-1. PubMed ID: 23880475
    [No Abstract]   [Full Text] [Related]  

  • 78. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
    Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
    Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stimulation by Monocyte Chemoattractant Protein-1 Modulates the Ex-vivo Colony Formation by Head and Neck Squamous Cell Carcinoma Cells.
    Wichmann G; Körner C; Boehm A; Mozet C; Dietz A
    Anticancer Res; 2015 Jul; 35(7):3917-24. PubMed ID: 26124338
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.